BioNTech SE (BNTX)
98.00
+1.30
(+1.34%)
USD |
NASDAQ |
Apr 14, 10:54
BioNTech Cash from Investing (TTM) : -2.797B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| GSK Plc | -7.740B |
| Merck & Co., Inc. | -13.74B |
| Novavax, Inc. | -78.27M |
| Novo Nordisk A/S | -12.02B |
| Moderna, Inc. | 1.946B |